Skip to main content

Table 2 Previous (cumulative) and current treatment of patients with 47 relapsing polychondritis

From: Demographic, clinical, treatment, outcome, and comorbidities of patients with relapsing polychondritis: experience from Brazilian tertiary center, and literature review

Treatment

Previous (cumulative)

Current

Glucocorticoid

  

 Pulse therapy with MP

11 (23.4)

0

 Using

39 (83.0)

17 (36.2)

 Dose (mg/day)

-

15 (15–30)

Intravenous immunoglobulin

4 (8.5)

0

Cyclophosphamide

14 (29.8)

0

Methotrexate

39 (83.0)

11 (23.4)

Azathioprine

21 (44.7)

8 (17.0)

Mycophenolate mofetil

10 (21.3)

1 (2.1)

Antimalarial

7 (14.9)

1 (2.1)

Leflunomide

6 (12.8)

1 (2.1)

Dapsone

3 (6.4)

0

Cyclosporine

4 (4.5)

1 (2.1)

Thalidomide

2 (4.3)

1 (2.1)

Immunobiological

12 (25.5)

7 (14.9)

  1. Data are expressed as median (interquartile 25th – 75th) or frequency (%)
  2. MP: methylprednisolone